Dr Joseph Ciccolini, Pharm.D. Ph.D., is Assistant Professor on Pharmacokinetics at Aix Marseille University and Clinical Pharmacologist at La Timone University Hospital of Marseille, France. Dr Ciccolini is the group leader of the SMARTc research unit and the head of the Master Degree in Pharmacokinetics of Aix Marseile University. Dr Ciccolini's expertise in clinics is mostly based on controling pharmacokinetics variability of anticancer agents, ranging from cytotoxics to targeted therapies and biotherapies, in a variety of settings. In particular, Dr Ciccolini has contributed to develop adaptive dosing strategies, including pharmacogenetic-based dosing algorithms, as a means to secure the administration of several nucleoside analogs. Dr Ciccolini's current work focus on developing therapeutic drug monitoring associated to adaptive dosing strategies with biologics, including immune check-point inhibitors. Dr Ciccolini has P.I.'ed or co-P.I.'ed several clinical trials investigating on the pharmacokinetics, pharmacodynamics and pharmacogenetics of a variety of anticancer drugs, has co-authored more than 120 international papers and owns several patents in the field. Joseph Ciccolini is the current chair of french GPCO-Unicancer society, and the board-member of the PAMM-EORTC group dedicated to pharmacokinetics and pharmacodynamics.